The role of c-myb during the maturation of murine CFU-E

Maureen Gilmore, Terry Rogers Bishop

Research output: Contribution to journalArticle

Abstract

Proper expression of the c-myb proto-oncogene is essential for definitive, but not primitive erythropoiesis. To examine the role of c-myb during adult erythropoiesis, we incubated purified murine colony-forming units (CFU-E) with a c-myb-specific antisense oligodeoxynucleotide (AS- oligo) in order to diminish expression levels. By western blot analysis, c- myb expression was reduced during the first seven hours of AS-oligo treatment as compared to untreated cells. We then quantitated the amount of heme synthesized in CFU-E treated with c-myb AS-oligo, a random sequence oligo or no oligo. No significant differences were seen in tile amount of heme synthesized during 42 hours of erythroid culture with either high levels (1 U/mL) or physiological levels (20 mU/mL) of Epo. In contrast, CFU-E treated with an AS-oligo directed toward mRNA encoding the first enzyme of the heme biosynthetic pathway in erythroid cells (d-aminolevulinate synthase) demonstrated a 65% reduction in the amount of heme synthesized. We conclude that the major role of c-myb during hematopoiesis must be in progenitor cells antecedent to the CFU-E stage and may possibly involve the establishment of the genetic program directing the formation of red blood cells.

Original languageEnglish (US)
Pages (from-to)68-77
Number of pages10
JournalBlood Cells, Molecules, and Diseases
Volume25
Issue number1
DOIs
StatePublished - Feb 1999

Fingerprint

Erythroid Precursor Cells
Heme
Erythropoiesis
Stem Cells
myb Genes
Erythroid Cells
Oligodeoxyribonucleotides
Biosynthetic Pathways
Hematopoiesis
Erythrocytes
Western Blotting
Messenger RNA
Enzymes

Keywords

  • Antisense oligodeoxynucleotides
  • C-myb
  • CFU-E
  • Erythropoietin
  • Heme

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Hematology

Cite this

The role of c-myb during the maturation of murine CFU-E. / Gilmore, Maureen; Bishop, Terry Rogers.

In: Blood Cells, Molecules, and Diseases, Vol. 25, No. 1, 02.1999, p. 68-77.

Research output: Contribution to journalArticle

@article{a774266f2f5e4cc19ea37dabff769b7d,
title = "The role of c-myb during the maturation of murine CFU-E",
abstract = "Proper expression of the c-myb proto-oncogene is essential for definitive, but not primitive erythropoiesis. To examine the role of c-myb during adult erythropoiesis, we incubated purified murine colony-forming units (CFU-E) with a c-myb-specific antisense oligodeoxynucleotide (AS- oligo) in order to diminish expression levels. By western blot analysis, c- myb expression was reduced during the first seven hours of AS-oligo treatment as compared to untreated cells. We then quantitated the amount of heme synthesized in CFU-E treated with c-myb AS-oligo, a random sequence oligo or no oligo. No significant differences were seen in tile amount of heme synthesized during 42 hours of erythroid culture with either high levels (1 U/mL) or physiological levels (20 mU/mL) of Epo. In contrast, CFU-E treated with an AS-oligo directed toward mRNA encoding the first enzyme of the heme biosynthetic pathway in erythroid cells (d-aminolevulinate synthase) demonstrated a 65{\%} reduction in the amount of heme synthesized. We conclude that the major role of c-myb during hematopoiesis must be in progenitor cells antecedent to the CFU-E stage and may possibly involve the establishment of the genetic program directing the formation of red blood cells.",
keywords = "Antisense oligodeoxynucleotides, C-myb, CFU-E, Erythropoietin, Heme",
author = "Maureen Gilmore and Bishop, {Terry Rogers}",
year = "1999",
month = "2",
doi = "10.1006/bcmd.1999.0228",
language = "English (US)",
volume = "25",
pages = "68--77",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - The role of c-myb during the maturation of murine CFU-E

AU - Gilmore, Maureen

AU - Bishop, Terry Rogers

PY - 1999/2

Y1 - 1999/2

N2 - Proper expression of the c-myb proto-oncogene is essential for definitive, but not primitive erythropoiesis. To examine the role of c-myb during adult erythropoiesis, we incubated purified murine colony-forming units (CFU-E) with a c-myb-specific antisense oligodeoxynucleotide (AS- oligo) in order to diminish expression levels. By western blot analysis, c- myb expression was reduced during the first seven hours of AS-oligo treatment as compared to untreated cells. We then quantitated the amount of heme synthesized in CFU-E treated with c-myb AS-oligo, a random sequence oligo or no oligo. No significant differences were seen in tile amount of heme synthesized during 42 hours of erythroid culture with either high levels (1 U/mL) or physiological levels (20 mU/mL) of Epo. In contrast, CFU-E treated with an AS-oligo directed toward mRNA encoding the first enzyme of the heme biosynthetic pathway in erythroid cells (d-aminolevulinate synthase) demonstrated a 65% reduction in the amount of heme synthesized. We conclude that the major role of c-myb during hematopoiesis must be in progenitor cells antecedent to the CFU-E stage and may possibly involve the establishment of the genetic program directing the formation of red blood cells.

AB - Proper expression of the c-myb proto-oncogene is essential for definitive, but not primitive erythropoiesis. To examine the role of c-myb during adult erythropoiesis, we incubated purified murine colony-forming units (CFU-E) with a c-myb-specific antisense oligodeoxynucleotide (AS- oligo) in order to diminish expression levels. By western blot analysis, c- myb expression was reduced during the first seven hours of AS-oligo treatment as compared to untreated cells. We then quantitated the amount of heme synthesized in CFU-E treated with c-myb AS-oligo, a random sequence oligo or no oligo. No significant differences were seen in tile amount of heme synthesized during 42 hours of erythroid culture with either high levels (1 U/mL) or physiological levels (20 mU/mL) of Epo. In contrast, CFU-E treated with an AS-oligo directed toward mRNA encoding the first enzyme of the heme biosynthetic pathway in erythroid cells (d-aminolevulinate synthase) demonstrated a 65% reduction in the amount of heme synthesized. We conclude that the major role of c-myb during hematopoiesis must be in progenitor cells antecedent to the CFU-E stage and may possibly involve the establishment of the genetic program directing the formation of red blood cells.

KW - Antisense oligodeoxynucleotides

KW - C-myb

KW - CFU-E

KW - Erythropoietin

KW - Heme

UR - http://www.scopus.com/inward/record.url?scp=0033082049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033082049&partnerID=8YFLogxK

U2 - 10.1006/bcmd.1999.0228

DO - 10.1006/bcmd.1999.0228

M3 - Article

C2 - 10349515

AN - SCOPUS:0033082049

VL - 25

SP - 68

EP - 77

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 1

ER -